'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases

Digestive Surgery

Volumn 25, Issue 6, 2009, Pages 430-435

  Mentha, Gilles ^a   Roth, Arnaud D ^a   Terraz, Sylvain ^a   Giostra, Emiliano ^a   Gervaz, Pascal ^a   Andres, Axel ^a   Morel, Philippe ^a   Rubbia Brandt, Laura ^a   Majno, Pietro E ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Advanced liver metastases; Chemotherapy; Liver sugery; Reverse strategy

Indexed keywords

BEVACIZUMAB; CETUXIMAB;

ADULT; AGED; ANASTOMOSIS LEAKAGE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; COLORECTAL TUMOR; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INFORMATION PROCESSING; INTESTINE OBSTRUCTION; LIVER INJURY; LIVER METASTASIS; LIVER RESECTION; MALE; RECTUM ANASTOMOSIS; SEPSIS; SURGICAL TECHNIQUE; SURVIVAL; SURVIVAL RATE; TREATMENT PLANNING;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PILOT PROJECTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 60149090706     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000184734     Document Type: Conference Paper

References (26)

1. De Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-2947.
2. Douillard JY, Cunningham D, Roth AD, et al: Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet 2000;355:1041-1047.
3. Falcone A, Masi G, Allegrini G, et al: Biweekly chemotherapy with oxaliplatin, irinotecan, infusional fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer. J Clin Oncol 2002;20:4006-4014.
4. Seium Y, Stupp R, Ruhstaller T, et al: Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study. Ann Oncol 2005;16:762-766.
5. Sheikh HY, Vall JW, Palmer K, et al: Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study. Br J Cancer 2007;96:38-43.
6. Van Cutsem E, Lang I, D'Haens G, Moiseyenko V, Zaluski J, Folprecht G, Tejpar S, Kisker O, Stroh C, Rougier P: KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience. J Clin Oncol 2008;26(suppl):1006s.
7. Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342.
8. Mentha G, Majno P, Terraz S, Rubbia-Brandt L, Gervaz P, Andres A, Allal AS, Morel P, Roth AD: Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour. Eur J Surg Oncol 2007;33:S76-S83.
9. Mentha G, Majno PE, Andres A, Rubbia-Brandt L, Morel P, Roth AD: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 2006;93:872-878.
10. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1,001 consecutive cases. Ann Surg 1999;230:309-318; discussion 318-321.
11. Rubbia-Brandt L, Audard V, Sartoretti P, Roth A, Brezault C, Le Charpentier M, Dousset B, Morel P, Soubrane O, Chaussade S, Mentha G, Terris B: Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004;15:460-466.
12. Vauthey JN, Pawlik TM, Ribeiro D, et al: Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065-2072.
13. Andres A, Majno PE, Morel P, Rubbia-Brandt L, Giostra E, Gervaz P, Terraz S, Allal AS, Roth AD, Mentha G: Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score. Ann Surg Oncol 2008;15:134-143.
14. Weber JC, Bachellier P, Oussoultzoglou E, Jaeck D: Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 2003;90:956-962.
15. Chua HK, Sondenaa K, Tsiotos GG, Larson DR, Wolff BG, Nagorney DM: Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum 2004;47:1310-1316.
16. Scheele J, Stangl R, Altendorf-Hofmann A: Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990;77:1241-1246.
17. Bismuth H, Adam R, Levi F, et al: Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-520.
18. Chua YJ, Cunningham D: Neoadjuvant chemotherapy of unresectable liver metastases from colorectal cancer. Clin Colorectal Cancer 2006;5:405-412.
19. Adam R, Pascal G, Castaing D, Azoulay D, Delvart V, Paule B, Levi F, Bismuth H: Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases? Ann Surg 2004;240:1052-1064.
20. Rubbia-Brandt L, Giostra E, Brezault C, et al: Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Ann Oncol 2007;18:299-304.
21. Adam R, Wicherts DA, De Haas RJ, et al: Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? J Clin Oncol 2008;26:1635-1641.
22. Law WL, Choi HK, Lee YM, Ho JWC: The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer. Ann Surg Oncol 2007;14:2559-2566.
23. Matthiessen P, Hallböök O, Rutegard J, Simert G, Sjödahl R: Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer. Ann Surg 2007;246:207-214.
24. Sauer R, Becker H, Hohenberger W, et al: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
25. Mala T, Bohler G, Mathisen O, Bergan A, Soreide O: Hepatic resection for colorectal metastases: can preoperative scoring predict patient outcome? World J Surg 2002;26:1348-1353.
26. Mann CD, Metcalfe MS, Leopardi LN, Maddern GJ: The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg 2004;139:1168-1172.